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Abstract
It is still unclear if performance recovery in postischemic hearts is related to their tissue level of high-energy phosphates before
reflow. To test the existence of this link, we monitored performance, metabolism and histological damage in isolated,
crystalloid-perfused rat hearts during 20 min of low-flow ischemia (90% coronary flow reduction) and reflow. To prevent
interference from different ischemia times and perfusing media compositions, the ischemic ATP level was varied by changing
energy demand (electrical pacing at 330 min–1). Under full coronary flow conditions, work output, as well as ATP and
phosphocreatine contents were the same in control, spontaneously contracting (n = 23) and paced (n = 21) hearts. During low-flow
ischemia, the higher work output (p < 0.0001) in paced hearts decreased their tissue content of ATP, phosphocreatine and total
adenylates and purines (p < 0.05), as opposed to maintained values in control hearts. During reflow, the recovery of mechanical
performance and O2 uptake was 94 ± 5% and 110 ± 9% (p = NS vs. baseline) in controls, vs. 71 ± 5% and 74 ± 6% in paced
hearts (p < 0.004 vs. baseline). The levels of ATP and total adenylates and purines remained constant in control, but were markedly
depressed (p < 0.05 vs. baseline) in paced hearts. Phosphocreatine+creatine was the same in both groups. These data, together
with the observed lack of creatine kinase leakage and of structural damage, indicate that myocardial recovery during reflow
reflects the tissue level of ATP, phosphocreatine and total adenylates and purines during ischemia, regardless of physical cell
damage. (Mol Cell Biochem 194: 245–249, 1999)
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Introduction
It is generally, although not universally, perceived that
biochemical factors critically control some of the mechanisms
underlying the myocardial dysfunction that follows ischemia-
reperfusion. One of these concerns the link between the
tissue level of high-energy phosphates, e.g. ATP and phos-
phocreatine (Pcr), measured in the ischemic myocardium
before reflow, and the functional postischemic recovery. This
link appears non-existent in some studies [1–4]. In contrast,
a causal relationship emerged in other models, where the
ischemic level of high-energy phosphates was altered either
by changing the length of ischemia [5, 6], or by replenishing
hearts with diffusable substrates [7–9]. However, the use of
pharmacological agents as well as of different ischemia times
might have confounded data, and the basic issue whether
myocardial biochemistry may eventually influence recovery
in postischemic hearts remains unresolved.
To focus on that issue, we realize that the ischemic ATP
level can be modified also by modulating energy demand
[10], without altering neither the time duration of ischemia
nor the composition of the perfusing medium. In this study,
we test the hypothesis that myocardial recovery during reflow
reflects the tissue level of ATP, Pcr and their catabolites
during ischemia. For this aim, we monitored performance,
metabolism and histological damage in isolated, perfused rat
hearts during low-flow ischemia and reflow. While the control
group is constituted by spontaneously contracting hearts, that
underwent downregulation of energy requirements [11],
propositus hearts are electrically paced to establish a condition
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of high energy demand, that would decrease the level of high
energy phosphates. We show that high demand of energy
decreases the myocardial functional recovery presumably by
decreasing the intracellular pool of ATP, but not that of Pcr, and
that this effect is independent of membrane damage.
Materials and methods
Materials
Hearts from ad libitum fed Sprague-Dawley male rats (wt 250–
280 g) were Langendorff-perfused [10] with Krebs-Henseleit
buffer (2.0 mM free Ca2+, 16.6 mM glucose, pH 7.4, PCO2 = 43
mmHg, PO2 = 670 mmHg, 37°C). All hearts (n = 44) were
stabilized for 30 min at 15 ml/min flow. A cannula was inserted
into the pulmonary artery to collect the venous return and to
monitor venous PO2 by an O2-sensing electrode (Yellow
Springs Inc. model 5300 Oxygen Monitor, Yellow Springs,
OH, USA). The balloon volume was adjusted to achieve end-
diastolic pressure (EDP) = 10 mmHg and was kept constant
throughout. Therefore, subsequent increases of EDP reflect
diastolic contracture. Paced hearts (n = 21) were electrically
stimulated at heart rate (HR) = 330 beats/min. Electrodes for
stimulation were placed on the aortic cannula and on the apex
of the ventricle and were connected to a square wave stim-
ulator (Harvard, South Natick, MA, USA, 5 msec pulse
duration, 10 V pulse amplitude). At the end of stabilization, 7
control and 6 paced hearts were freeze-clamped with liquid
nitrogen cooled clamps for baseline measurements. The
remaining hearts underwent 20 min of low-flow ischemia (flow
= 1.5 ml/min). At the end of this period, 7 control and 6 paced
hearts were freeze-clamped for metabolite measurements. The
remaining hearts underwent 20 min of reflow (flow = 15 ml/min),
and were finally freeze-clamped for metabolites determination.
Measurements and calculations
Contractility measurements included EDP, HR and left-
ventricle developed pressure (LVDP). The product LVDP·HR
provides an index of the isovolumic work output. The O2
uptake (VO2) was calculated from venous PO2 and coronary
flow. Frozen tissue was extracted with perchloric acid and
assayed for Pcr, creatine, ATP, ADP, AMP, adenosine,
inosine-5 ¢ -monophosphate, inosine, hypoxanthine, xanthine
and urate by high-pressure liquid chromatography [12]. The
sum of these compounds, except Pcr and creatine, is referred
to as total adenine nucleotides and purines (TANP).
Endothelial damage was evaluated at the end of both
baseline and reflow in two additional hearts per group. At the
selected times, the heart was perfused for 4 min with
colloidal carbon black solution (Rotring, Hamburg, Ger-
many, 1/200 v/v in buffer), followed by 2 min of washout
with the perfusing medium [13]. The heart was removed from
the apparatus, 5 samples of the organ were fixed in 10%
paraformaldehyde and stored at –80°C until conventional
hematology (hematoxylin-eosin staining) was carried out. The
retention of carbon black ink in the interstitium, estimated by
optical microscopy on a scale ranging from 1 (no retention)
to 4 (maximal retention), is proportional to endothelial cell
injury. Grade 4 was arbitrarily assigned to hearts exposed to
20 min of perfusion at PO2 = 67 mmHg followed by 20 min
of reoxygenation as in group A of [11].
Myocyte injury was evaluated in two additional hearts per
group at the end of both baseline and reflow by electron
microscopy as described [11]. For this evaluation, the heart
was freeze-clamped in pre-cooled isopentane. We evaluated
the damage to nuclei (margination and clumping of chro-
matin), mitochondria (enlargement, matrix density, disruption
of cristae and occurrence of amorphous material) and myo-
cardial fibers (occurrence and severity of contraction bands),
as well as cell edema, on a scale ranging from 1 (no injury)
to 4 (maximal injury) [14], where Grade 4 was assigned as
above. The damage to membrane was evaluated using the
following arbitrary criteria applied to the membrane outline:
smooth (grade 1), slightly wrinkled (grade 2), heavily
wrinkled (grade 3), irregular and influenced by intracellular
structures (grade 4).
To further assess myocyte injury, we assayed creatine
kinase activity in the effluent collected for 10 min after reflow
in 4 hearts per group. Standard UV methods (CK-NAC,
Behring, L’Aquila, Italy) were employed.
Statistics
Data (means ± S.E.) were collected at the end of the periods
of baseline, underperfusion and reflow. The recovery was
assessed by dividing the value obtained at the end of reflow
by that obtained at the end of baseline. Differences were
tested by the parametric Student’s t-test for unpaired
observations (significance level, p = 0.05, two-tailed).
Results
Function
Since hearts kept contracting during low-flow ischemia and
reflow, all experiments are suitable for analysis. During
baseline, HR was higher in paced than in control hearts
(Table 1), but LVDP·HR was unchanged, because LVDP
decreased proportionally. VO2 was slightly higher in control
than paced hearts (venous PO2 = 348 ± 22 and 299 ± 13
mmHg, respectively, p = NS). During low-flow ischemia,
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LVDP·HR declined in both groups. The venous PO2 were
100 ± 13 and 137 ± 20 mmHg, leading to almost identical
VO2 values. After reflow, both diastolic contracture and
myocardial dysfunction were higher in paced than in control
hearts. VO2 was also more depressed in paced hearts. In
contrast, spontaneously contracting hearts could recover
almost completely their baseline performance.
Metabolism
During baseline, metabolic data were the same in the two
groups, with the exception of higher inosine-5¢ -monophos-
phate in paced hearts (Fig. 1). While the ATP and TANP
levels remained unchanged throughout ischemia-reperfusion
in control hearts, they decreased markedly in paced hearts.
The sum Pcr+creatine was unaltered in both groups. In paced
hearts, Per first decreased, then overshot above baseline,
while remaining unchanged in control hearts. Inosine-
5 ¢ -monophosphate was higher in paced than control hearts
during low-flow ischemia, but at the end of reflow this value
was the same in both groups.
Cell damage
No evident sign of cell damage was observed in the two groups:
(i) Creatine kinase activity in the effluent collected during the
first 5 min of reflow did not exceed 0.03 U/l in both control
and paced hearts; (ii) Ultrastructural data indicate only minor
damage at the level of mitochondria, nuclei and myofibrils
(Table 2); and (iii) Ink retention, index of endothelial damage,
was similar in control and paced hearts.
Discussion
In fully perfused hearts, the increase in HR due to pacing
offsets the decrease in LVDP, in agreement with [15]:
Therefore, LVDP·HR provides a reliable index of the
isovolumic work output. Pacing does not alter the tissue
high-energy phosphates level, index of energy balance,
because the saturating supply of O2 and substrate [16] allows
tight coupling between ADP phosphorylation and ATP
dephosphorylation. Although some ATP is likely converted
to its catabolites even under baseline conditions, purine
salvage and de novo purine synthesis compensate the loss of
these compounds [17]. The higher level of inosine-5 ¢ -mono-
phosphate in paced than control hearts may be due to
adrenergic stimulation that enhances AMP conversion to
inosine-5¢ -monophosphate by activating AMP deaminase [18].
During low-flow ischemia in spontaneously contracting
hearts, intracellular lactate accumulation downregulates
myocardial activity [16]. Thus, the tissue levels of ATP, Pcr
and inosine-5 ¢ -monophosphate do not change appreciably.
Indeed, the favourable perfusion-contraction matching allows
balanced energy supply-to-demand ratio despite severe flow
reduction. During low-flow ischemia in paced hearts, energy
demand increases under conditions of limited supply of O2
and substrate. This ‘unmatches’ the energy supply-to-demand
balance. The high level of inosine-5¢ -monophosphate indicates
a situation of bioenergetic derangement [10]. Although
LVDP·HR does not change with pacing, increased EDP raises
the performance level: (LVDP+EDP)·HR, an expression of
total work output, is 6.2 ± 0.5 mmHg·103/min and 9.9 ± 0.7
mmHg·103/min (p < 0.0001), respectively, in control and
paced hearts. VO2 is the same in both groups during low-flow
Table 1. Myocardial perfonnance at the end of the various phases in control (spontaneously contracting) and paced hearts
Heart rate End- Developed LVDP·HR O2 uptake
diastolic pressure
pressure
beats/min mmHg mmHg mmHg·103/min µmoles/min
Control
Baseline (n = 23) 270 ± 8 9.5 ± 0.5 150 ± 5 40.6 ± 1.9 6.8 ± 0.5
Low-flow ischemia 178 ± 12# 5.2 ± 0.4# 31 ± 4# 5.2 ± 0.5# 1.2 ± 0.1
(n = 16)
Reflow (n = 9) 264 ± 15 7.8 ± 0.6 138 ± 5# 36.7 ± 2.8 7.5 ± 0.9
% Recovery 99 ± 4 79  ± 7 96 ± 2 94 ± 5 110 ± 9
Paced
Baseline (n = 21) 330 ± 0* 9.6 ± 0.3 113 ± 3* 37.3 ± 1.1 7.8 ± 0.3
Low-flow ischemia 330 ± 0* 13.2 ± 0.5*# 17 ± 1*# 5.5 ± 0.5# 1.1 ± 0.1
(n = 15)
Reflow (n = 9) 330 ± 0* 30.2 ± 3.5*# 81 ± 5*# 26.6 ± 1.6*# 5.8 ± 0.4*#
% Recovery 100 292  ± 37 71 ± 5 71  ± 5 74 ± 6
Data obtained at the end of baseline, after 20 min of low-flow ischemia, and after 20 min of reflow (mean ± S.E.). *Significant difference (p < 0.05) vs.
spontaneously beating hearts; #Significant difference (p < 0.05) vs. baseline (Student’s t-test). LVDP·HR, developed pressure·heart rate.
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Fig. 1. Tissue levels (µmoles/g dry wt) in spontaneously contracting
(control, squares) and paced (circles) hearts, during baseline (n = 7 and 6,
respectively), after 20 min of low-flow ischemia (n = 7/6), and after 20
min of reflow (n = 9/8) (mean ± S.E.). *Significant difference (p < 0.05)
vs. spontaneously contracting hearts; #Significant difference (p < 0.05) vs.
baseline (Student’s t-test).
Table 2. Structural and ultrastructural damage at the end of baseline and
reflow in spontaneously contracting (control) and paced hearts
Baseline Reflow
Control Paced
Ink retention 1 1 1.5
Nucleus 1 1.5 1.5
Mitochondria 1 1 1.5
Myofibrils 1.5 1.5 2
Edema 1.5 2 2
Membrane 1 2 2
Average score 1.2 1.5 1.7
The damage was evaluated on a 1 to 4 scale as explained in the text, grade
4 showing maximal damage (see text for details, n = 2 hearts per group).
ischemia: Thus, anaerobic glycolysis contributes the extra ATP
needed to support the increased work output in paced hearts
[16]. As a consequence of impaired energy supply with respect
to demand, the ATP and Pcr levels decline more markedly in
paced than in control hearts. Enhanced ATP catabolism
increases inosine-5 ¢ -monophosphate, and decreases TANP. In
principle, the latter finding may be attributed to the leak of
intracellular compounds secondary to aspecific membrane
damage. However, electron and optical microscopy, as well as
creatine kinase release, exclude this possibility. Furthermore,
constant Pcr+creatine does not support permeability increase,
because these compounds do not leak across intact membrane
[19, 20]. Therefore, the loss of TANP is attributed to passive
diffusion of uncharged ATP catabolites (adenosine, inosine,
hypoxanthine, xanthine and urate) across the membrane.
Performance recovery during reflow is generally considered
as an integrated index of myocardial viability. Although we can
not rule out some contribution of the right ventricle, the left
ventricle is presumably mostly involved in the observed
patterns. Improved recovery in spontaneously contracting with
respect to paced hearts reflects their less severe metabolic
derangement during ischemia. Although paced hearts are likely
able to resynthesize some ATP from its catabolites during
reflow, the low level of TANP prevents full restoration of the
ATP pool. This compromises performance recovery [7, 21, 22].
The Pcr overshoot during reflow is due to low ADP availability
for the creatine-kinase reaction.
In conclusion, high energy demand during ischemia com-
promises performance recovery during reflow presumably by
biochemical mechanisms. Enhanced ATP degradation, secon-
dary to high energy demand, forms uncharged, membrane-
diffusable ATP catabolites, that can be washed out by residual
flow. This reduces the intracellular ATP pool and compromises
recovery during reflow. This mechanism is unrelated to
membrane damage and to phenomena associated with the
presence of blood. Therefore, some other derangements, that
are recognised as part of the ischemia-reperfusion dysfunction
in vivo, as for example Ca2+ transients changes, free radical
injury, and microcirculatory consequences, presumably follow,
and do not precede, myocardial metabolism changes [23]. As
some of the involved mechanisms are not structurally veri-
fiable, our conclusion is to be checked against further data
aimed at demonstrating this particular sequence of events
during ischemia-reflow.
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